Both in Pharmaceuticals
Immunic vs NRX Pharmaceuticals
Over the past year IMUX returned +1.9% and NRXP returned −20.4%; their daily moves had a correlation of 0.05.
IMUX +1.9% NRXP −20.4%Growth of $1, one year, split-adjusted
| Metric | IMUX | NRXP |
|---|---|---|
| Price | $7.63 | $2.27 |
| Market cap | $104.0M | $98.3M |
| Today | +3.88% | +4.61% |
| 1 month | −5.5% | −20.9% |
| 6 months | −32.4% | −25.3% |
| Year to date | +42.9% | −16.2% |
| 1 year | −2.1% | −26.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 38.7% |
| Net margin | — | −1500.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 29.0× |
| Net cash | $155.1M | $26.3M |
| Dividend yield | — | — |
| Volatility (60d) | 75.8% | 57.7% |
| Short % of float | 17.5% | 29.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).